Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin), IgG1

Produktübersicht

• Artikelname: Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin), IgG1
• Artikelnummer: SYB-CHB252
• Hersteller Artikelnummer: CHB252
• Alternativnummer: SYB-CHB252-100UG,SYB-CHB252-1MG
• Hersteller: Sanyou Bio
• Kategorie: Antikörper
• Applikation: ELISA, FA, FACS, Kinetics
• Spezies Reaktivität: Human
• Alternative Synonym: SGN-35, cAC10-vcMMAE, AC10

Produktbeschreibung

Brentuximab vedotin is an ADC consisting of a CD30-directed antibody and Monomethyl auristatin E (MMAE) that inhibits CD30-positive cells and is used for the study of relapsed and refractory Hogkins lymphoma.

Produkteigenschaften

• Konzentration: 1mg/ml
• Molekulargewicht: 145.48 kDa
• Isotyp: IgG1
• NCBI: 28908
• Puffer: 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
• Reinheit: >90%
• Formulierung: Lyophilized
• Target-Kategorie: TNFRSF8 / CD30